79 related articles for article (PubMed ID: 8866768)
21. Discontinuing and switching antipsychotic medications: understanding the CATIE schizophrenia trial.
Weiden PJ
J Clin Psychiatry; 2007; 68 Suppl 1():12-9. PubMed ID: 17286523
[TBL] [Abstract][Full Text] [Related]
22. Integrating non-drug treatments in early schizophrenia.
Lewis SW; Tarrier N; Drake RJ
Br J Psychiatry Suppl; 2005 Aug; 48():s65-71. PubMed ID: 16055811
[TBL] [Abstract][Full Text] [Related]
23. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
24. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
Kilian R; Angermeyer MC
Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477
[TBL] [Abstract][Full Text] [Related]
25. Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences.
Dickey B; Normand SL; Eisen S; Hermann R; Cleary P; Cortés D; Ware N
Med Care; 2006 Sep; 44(9):827-34. PubMed ID: 16932134
[TBL] [Abstract][Full Text] [Related]
26. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
[TBL] [Abstract][Full Text] [Related]
27. A group approach to psychopharmacology with schizophrenics.
Skolnick MR
Yale J Biol Med; 1985; 58(4):317-26. PubMed ID: 2864762
[TBL] [Abstract][Full Text] [Related]
28. Maintenance treatment of schizophrenia: a review of dose reduction and family treatment strategies.
Schooler NR; Keith SJ; Severe JB; Matthews SM
Psychiatr Q; 1995; 66(4):279-92. PubMed ID: 8584586
[TBL] [Abstract][Full Text] [Related]
29. Psychoeducational family therapy for schizophrenia: a review essay.
Steinglass P
Psychiatry; 1987 Feb; 50(1):14-23. PubMed ID: 3575550
[TBL] [Abstract][Full Text] [Related]
30. Integrating pharmacological and psychosocial treatments for schizophrenia.
Marder SR
Acta Psychiatr Scand Suppl; 2000; (407):87-90. PubMed ID: 11261649
[TBL] [Abstract][Full Text] [Related]
31. The limitations of antipsychotic medication on schizophrenia relapse and adjustment and the contributions of psychosocial treatment.
Hogarty GE; Ulrich RF
J Psychiatr Res; 1998; 32(3-4):243-50. PubMed ID: 9793877
[TBL] [Abstract][Full Text] [Related]
32. [Follow-up of the schizophrenic patient by the general practitioner].
Wallot H
Union Med Can; 1983 Mar; 112(3):268-71. PubMed ID: 6134370
[No Abstract] [Full Text] [Related]
33. Role of psychosocial treatments in management of schizophrenia: a meta-analytic review of controlled outcome studies.
Mojtabai R; Nicholson RA; Carpenter BN
Schizophr Bull; 1998; 24(4):569-87. PubMed ID: 9853790
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of schizophrenia].
Peyron-Fourcade I
Soins Psychiatr; 1988 Mar; (89):27-30. PubMed ID: 2898171
[No Abstract] [Full Text] [Related]
35. Poor response to treatment: beyond medication.
Carvajal C
Dialogues Clin Neurosci; 2004 Mar; 6(1):93-103. PubMed ID: 22034452
[TBL] [Abstract][Full Text] [Related]
36. Implications of family studies for the treatment of schizophrenia.
Mosher LR
Ir Med J; 1976 Oct; 69(17):456-63. PubMed ID: 1033170
[No Abstract] [Full Text] [Related]
37. [Family reception. Presentation and functioning of the team].
Bloch JM; Vitse F; Guiter B
Soins Psychiatr; 1994 Feb; (160):4-9. PubMed ID: 7809695
[No Abstract] [Full Text] [Related]
38. [The sanatorium in the general therapeutic plan in schizophrenia].
BRIGL H; LINDINGER H
Wien Med Wochenschr; 1962 Mar; 112():255-7 concl. PubMed ID: 13873079
[No Abstract] [Full Text] [Related]
39. [Treatment of schizophrenia].
Petrova ES; Rukosuev AI
Med Sestra; 1982 Jan; 41(1):26-8. PubMed ID: 6917010
[No Abstract] [Full Text] [Related]
40. Adding a psychosocial intervention to antipsychotic medication reduces treatment discontinuation and relapse.
Mortimer AM
Evid Based Ment Health; 2011 Feb; 14(1):24. PubMed ID: 21266621
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
